Among older patients with inflammatory bowel disease, investigators found deficits in geriatric assessments were highly prevalent, according to a study in Clinical Gastroenterology and Hepatology. “[Our] findings underline the...
Read MoreSurvey results supported prior research that found one-quarter to one-third of patients with inflammatory bowel diseases report posttraumatic stress symptoms linked to their disease experience. To better characterize...
Read MoreResearchers observed no significant changes in inflammatory bowel disease activity among patients who had COVID-19, according to a study published in Clinical Gastroenterology and Hepatology. “With the increased frequency of new...
Read MoreNeither Entyvio nor Stelara plus immunomodulators were as effective as other therapies for inflammatory bowel disease, according to research at Digestive Disease Week. “When used with an immunomodulator (ie, azathioprine,...
Read MoreAbivax announced positive phase 2b clinical induction and results for ABX464 in the treatment of patients with moderate to severe ulcerative colitis, according to a press release. In a randomized, double-blind,...
Read More
CONCLUSIONS: Compared to the general population, IBD patients on biologic therapy are not exposed to a higher risk of COVID-19. Non-gut selective agents are associated with a lower incidence of symptomatic disease, supporting...
Read MoreCONCLUSION: CSI may replace endoscopic monitoring in pediatric CD. Radiological remission status predicts long-term disease outcomes. Full Text Link: https://libkey.io/34159487?utm_source=ibdwatch
Read MoreCONCLUSION: UST is safe and effective in elderly CD. Although limited by sample size and retrospective design, such real-world data can inform biologic positioning in this IBD population. Full Text Link:...
Read MoreCONCLUSIONS: Safety and effectiveness of ABP 501 seem to be overall similar to those reported for ADA originator. Switching from originator to ABP 501 was safe and effective. Full Text Link:...
Read MoreCONCLUSION: Deficits in geriatric assessment are highly prevalent in older patients with IBD. Patients with active disease are more prone to deficits, and deficits associate with lower HRQoL, indicating higher disease burden....
Read More